Markets Ahead

• Market volatility is expected this week due to fresh military strikes between the U.S. and Iran and upcoming comments from Nvidia CEO Jensen Huang on Artificial General Intelligence. • The Japanese yen has surged to a six-month high as investors place aggressive bets on interest rate hikes from the Bank of Japan. • These geopolitical tensions and currency shifts create immediate risk for global traders and the value of the U.S. dollar.

• European shares declined recently as rising oil prices put downward pressure on the market. • Oil prices are currently holding near six-week highs following attacks involving the US and Iran. • Novartis shares experienced a slip during this period of market volatility.

• Agricultural markets face volatility from September 7–11, 2026, as traders react to new inflation data and USDA reports. • Market pressures are driven by specific trade deadlines involving Canada tariffs, cattle flows from Mexico, and trade preparations with China. • These developments create immediate price risks for farmers and traders managing international exports and livestock shipments.

• Asia-Pacific markets remained steady on Friday, September 4, 2026, as investors awaited the release of critical US payrolls data. • Regional equities rose following a strong Wall Street session, with Japan's Nikkei increasing by approximately 1% and South Korea's Kospi climbing 1.3%. • Currency markets saw shifts as NZD/USD recovered above 0.5900 and USD/JPY regained the 156 level, while oil prices remained near recent highs.

• Stock markets are expected to be highly volatile in the coming week, driven primarily by the release of domestic GDP data and global economic reports. • Key indicators influencing market movement will include crude oil price fluctuations, auto sales numbers, and the trading activity of foreign investors. • These macroeconomic data points are critical as they provide insight into economic health and investor sentiment, which directly dictate market direction.

• The FTSE 100 saw gains today, driven primarily by a rally in mining stocks and a rebound in oil prices triggered by tensions in the Strait of Hormuz. • Pharmaceutical giant AstraZeneca has announced the cancellation of a late-stage lung cancer trial following a significant data setback. • These developments highlight current market volatility stemming from geopolitical instability in the Middle East and setbacks in the biotech sector.

• European stocks remained largely flat on Wednesday, with the pan-European STOXX 600 index holding steady at 661.26 points. • Investors are maintaining a cautious stance as they evaluate recent corporate earnings reports and rising geopolitical tensions. • The market is currently in a holding pattern as traders await the release of crucial US inflation data, which will likely influence global monetary policy.